Answers are grounded in this paper and cite their sources.
Substantive and significant differences between Medicaid and commercial claimants suggest that using all-payer claims provides a richer and more complete method for health surveillance of people with IDD.
No takes yet. Share an insight, caveat, or question.
Phillips et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: